Bio-Path Holdings - 19 Year Stock Price History | BPTH

Historical daily share price chart and data for Bio-Path Holdings since 2006 adjusted for splits and dividends. The latest closing stock price for Bio-Path Holdings as of May 07, 2025 is 0.18.
  • The all-time high Bio-Path Holdings stock closing price was 22960.00 on May 13, 2008.
  • The Bio-Path Holdings 52-week high stock price is 4.55, which is 2427.8% above the current share price.
  • The Bio-Path Holdings 52-week low stock price is 0.12, which is 33.3% below the current share price.
  • The average Bio-Path Holdings stock price for the last 52 weeks is 1.04.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bio-Path Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.4026 1.1500 1.1600 0.1322 0.1774 -84.71%
2024 3.0974 9.8500 11.2000 0.6100 1.1600 -87.47%
2023 22.7298 30.0000 45.2000 7.1000 9.2600 -69.34%
2022 65.0679 83.0000 88.6000 26.4000 30.2000 -59.95%
2021 113.4654 72.6000 235.4000 72.6000 75.4000 7.71%
2020 97.5477 165.2000 165.2000 61.4000 70.0000 -56.20%
2019 234.5905 76.0000 777.2000 35.0000 159.8000 128.29%
2018 545.5173 839.6000 996.0000 63.2000 70.0000 -91.36%
2017 2090.0414 5000.0000 5080.0000 800.0000 810.0000 -85.00%
2016 6980.9175 5120.0000 11760.0000 3890.4000 5400.0000 8.00%
2015 6073.6508 10640.0000 10640.0000 4000.0000 5000.0000 -53.01%
2014 11657.8095 16120.0000 19760.0000 7840.0000 10640.0000 -33.50%
2013 4114.0282 1280.0000 16000.0000 1200.0000 16000.0000 1042.86%
2012 1343.8600 1400.0000 1680.0000 520.0000 1400.0000 0.00%
2011 1513.3838 1580.0000 2200.0000 1040.0000 1400.0000 -0.57%
2010 1623.4392 1720.0000 2400.0000 1000.0000 1408.0000 -18.14%
2009 1251.5722 2200.0000 4000.0000 480.0000 1720.0000 -21.82%
2008 7719.5699 3600.0000 22960.0000 800.0000 2200.0000 -36.78%
2007 2285.7143 2440.0000 3600.0000 1400.0000 3480.0000 2.35%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.001B $0.000B
BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $94.222B 35.35
Zoetis (ZTS) United States $71.986B 26.86
Daiichi Sankyo, - (DSNKY) Japan $47.632B 24.23
Takeda Pharmaceutical (TAK) Japan $45.406B 9.03
Sandoz Group AG (SDZNY) Switzerland $19.756B 0.00
Summit Therapeutics (SMMT) United States $18.307B 0.00
Merck (MKKGY) Germany $17.693B 14.64
United Therapeutics (UTHR) United States $13.893B 12.29
Shionogi (SGIOY) Japan $13.832B 13.86
Neurocrine Biosciences (NBIX) United States $11.630B 39.84
IPSEN (IPSEY) France $9.997B 0.00
Orion OYJ (ORINY) Finland $8.541B 23.10
Corcept Therapeutics (CORT) United States $7.569B 61.53
Stevanato Group S.p.A (STVN) Italy $6.808B 41.63
Madrigal Pharmaceuticals (MDGL) United States $6.651B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.212B 0.00
Grifols, S.A (GRFS) Spain $5.019B 0.00
Soleno Therapeutics (SLNO) United States $3.843B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.062B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.776B 9.73
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.312B 12.64
NewAmsterdam Pharma (NAMS) Netherlands $2.116B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.765B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.650B 0.00
Guardian Pharmacy Services (GRDN) United States $1.613B 0.00
Indivior (INDV) United States $1.514B 6.42
Evotec AG (EVO) Germany $1.388B 0.00
ARS Pharmaceuticals (SPRY) United States $1.325B 168.62
Dyne Therapeutics (DYN) United States $1.283B 0.00
Ocular Therapeutix (OCUL) United States $1.187B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.108B 45.06
Enliven Therapeutics (ELVN) United States $0.914B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Collegium Pharmaceutical (COLL) United States $0.876B 4.73
Ardelyx (ARDX) United States $0.871B 0.00
Harrow (HROW) United States $0.865B 0.00
Xeris Biopharma Holdings (XERS) United States $0.807B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Akebia Therapeutics (AKBA) United States $0.686B 0.00
AleAnna (ANNA) United States $0.679B 0.00
Organogenesis (ORGO) United States $0.677B 0.00
Xencor (XNCR) United States $0.625B 0.00
KalVista Pharmaceuticals (KALV) United States $0.606B 0.00
Bioventus (BVS) United States $0.557B 14.17
Savara (SVRA) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.543B 11.81
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.495B 0.00
Elite Pharmaceuticals (ELTP) United States $0.466B 0.00
Altimmune (ALT) United States $0.447B 0.00
Zevra Therapeutics (ZVRA) United States $0.426B 0.00
CytoDyn (CYDY) United States $0.417B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.404B 0.00
Verve Therapeutics (VERV) United States $0.399B 0.00
Siga Technologies (SIGA) United States $0.389B 8.12
Oruka Therapeutics (ORKA) United States $0.365B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.13
Heron Therapeutics (HRTX) United States $0.331B 0.00
Aquestive Therapeutics (AQST) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.27
Avita Medical (RCEL) United States $0.247B 0.00
Wellgistics Health (WGRX) United States $0.216B 0.00
ProKidney (PROK) United States $0.205B 0.00
OmniAb (OABI) United States $0.192B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Esperion Therapeutics (ESPR) United States $0.177B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Nanobiotix S.A (NBTX) France $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.156B 0.00
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.145B 0.00
Larimar Therapeutics (LRMR) United States $0.143B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Lyell Immunopharma (LYEL) United States $0.126B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.113B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Lexeo Therapeutics (LXEO) United States $0.100B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Cassava Sciences (SAVA) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Corbus Pharmaceuticals Holdings (CRBP) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 50.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Surrozen (SRZN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
BioVie (BIVI) United States $0.023B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.52
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00